Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgr...
Dr Sara Hurvitz - University of California, Los Angeles, USA
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups ( Dr Sara Hurvitz - University of California, Los Angeles, USA )
21 Dec 2021
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + tr...
Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for triple-negative disease ( Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Dec 2021
Efficacy and safety of selinexor in patients with myelofibrosis refractory or in...
Prof Srinivas Tantravahi - University of Utah, Salt Lake City, USA
Efficacy and safety of selinexor in patients with myelofibrosis refractory or intolerant to JAK inhibitors ( Prof Srinivas Tantravahi - University of Utah, Salt Lake City, USA )
20 Dec 2021
Significance of gut microbiota in patients receiving CAR T cell immunotherapy
Prof Marco Ruella - University of Pennsylvania, Philadelphia, USA
Significance of gut microbiota in patients receiving CAR T cell immunotherapy ( Prof Marco Ruella - University of Pennsylvania, Philadelphia, USA )
17 Dec 2021
The RxPONDER trial and its impact on best clinical practice
Prof Christos Markopoulos and Prof Giuseppe Curigliano
The RxPONDER trial and its impact on best clinical practice ( Prof Christos Markopoulos and Prof Giuseppe Curigliano )
17 Dec 2021
WHO and St. Jude Children’s research hospital to dramatically increase global ac...
Dr Andre Llbawi - World Health Organization (WHO) Global Childhood Cancer Initia...
WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine ( Dr Andre Llbawi - World Health Organization (WHO) Global Childhood Cancer Initiative )
17 Dec 2021
The global platform for access to childhood cancer medicines
Dr James Downing - St. Jude Children’s Research Hospital, Memphis, USA
The global platform for access to childhood cancer medicines ( Dr James Downing -  St. Jude Children’s Research Hospital, Memphis, USA )
17 Dec 2021
Cancer medicine shortages for children around the world
Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis, US...
Cancer medicine shortages for children around the world ( Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis, USA )
17 Dec 2021
OncoAlert and ecancer round up: SABCS 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer round up: SABCS 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
16 Dec 2021
INTEGRATE study: Treatment pathways, outcomes and resource use in patients with ...
Prof Meral Beksac and Prof Roman Hájek
INTEGRATE study: Treatment pathways, outcomes and resource use in patients with multiple myeloma ( Prof Meral Beksac and Prof Roman Hájek )
15 Dec 2021
Silver linings: a qualitative study of desirable changes to cancer care during t...
Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe - Re...
Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic ( Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe - Regional Cancer Treatment Service, Palmerston North, New Zealand )
15 Dec 2021
Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-lin...
Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands
Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients ( Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands )
14 Dec 2021